Navigation Links
Press statement on new CDC MRSA study from SHEA president
Date:2/17/2009

A new study from the Centers for Disease Control and Prevention (CDC) shows a decrease in catheter-associated bloodstream infections caused by both methicillin-resistant and methicillin-sensitive S. aureus. The 10-year national study, 'Methicillin-Resistant Staphylococcus aureus Central Line-Associated Bloodstream Infections in US Intensive Care Units, 1997,' reported data from both the National Nosocomial Infection Surveillance (NNIS) and its successor, the National Healthcare Safety Network (NHSN). The study demonstrates a steady decline in intensive care unit catheter-associated MRSA bloodstream infections since 2001.

Below Are Quotes from Mark Rupp, MD, President of SHEA

"Despite the fact that MRSA prevalence continues to rise, efforts to prevent catheter infections are paying dividends and the number of infections due to all types of Staphylococcus aureus, including MRSA, have been falling sharply since 2001. Therefore, simply examining the percentage of staphylococcal isolates that are MRSA can be a misleading indicator of the burden of disease caused by this organism."

"The rate of these infections is decreasing and hospitals are becoming safer for patients because hospitals are instituting and adhering to general practices that result in fewer infections, including measures to ensure proper catheter insertion and removal, hand hygiene, environmental cleanliness, and antimicrobial stewardship.

"Because MRSA only causes about 8% of healthcare-associated infections, it is critical that we not concentrate all of our preventive efforts on a single bacterium. Undue emphasis on a single organism like MRSA can dilute broader-based measures that can have a dramatic effect on infections caused by many different organisms.

"This study illustrates that it is more important for hospitals to focus on the infections and diseases that the germs cause rather than the germs themselves. Decreasing the infections will decrease the burden of disease caused by all resistant organisms and not just MRSA."


'/>"/>

Contact: Sharon Reis
sreis@gymr.com
202-745-5103
GYMR
Source:Eurekalert

Related biology news :

1. Molecule that suppresses immune response under study in type 1 diabetes
2. UNC study: Tinkering with the circadian clock can suppress cancer growth
3. Pregnancy hormone predicts postpartum depression
4. American Chemical Societys Weekly PressPac -- Jan. 28, 2009
5. DNA component can stimulate and suppress the immune response
6. Cutting salt isnt the only way to reduce blood pressure
7. American Chemical Societys weekly PressPac -- Jan. 14, 2009
8. American Chemical Societys Weekly PressPac -- Jan. 7, 2009
9. Facial expressions of emotion are innate, not learned, says new study
10. Krumlauf Lab demonstrates modulation of gene expression by protein coding regions
11. American Chemical Societys Weekly PressPac -- Dec. 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... announces that it has just released a new white paper authored by Zettar that ... speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a ...
(Date:11/15/2016)... Nov 15, 2016 Research and Markets has ... to 2021" report to their offering. ... ... Billion by 2021 from USD 6.21 Billion in 2016, growing at ... Growth of the bioinformatics market is driven by the growing demand ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes ... standardization and a beautiful technology experience. All three tenets were on display at the ... trial leaders from over 40 sponsor, CRO and site organizations to discuss innovation and ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... to announce the formation of EyGen, Ltd. a ... assets through proof of concept. EyGen,s lead asset ... Pharmaceuticals Limited and being developed for topical ophthalmic ... segment diseases. This agent has the potential to ...
(Date:11/30/2016)... and BEIJING , Nov. 30, ... commercial provider of genomic services and solutions with cutting ... that it has completed a USD $75 Million [515 ... Co., Ltd.,s CMB International Capital Management ( Shenzhen ... Management Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square ...
Breaking Biology Technology: